Physician profile
Vikram Chatrath
NPI 1205264074
$9,369.12
in general payments reported to CMS, 2019-2025
20 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,077 · 2020: $2,553 · 2021: $500 · 2022: $3,241 · 2023: $1,536 · 2024: $305 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,072 · Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,071.83 |
| Food and Beverage | $925.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,708.17 | 2019-2023 | Rosa, Tapestry |
| Midsouth Orthopedics INC. | $1,200.00 | 2022 | |
| Medtronic USA, INC. | $1,155.62 | 2020 | |
| Maxx Orthopedics, INC. | $1,009.72 | 2019 | |
| Stryker Corporation | $894.17 | 2021-2025 | Gamma, Mako |
| Gemini Medical LLC | $667.00 | 2020 | |
| Depuy Synthes Sales INC. | $217.38 | 2021-2023 | Fibergraft Bg Morsels |
| Arthrex, INC. | $113.04 | 2022 | |
| Smith+Nephew, INC. | $98.75 | 2022-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl |
| Kerecis Limited | $56.68 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Orthofix Medical, INC. | $44.23 | 2019 | |
| Medtronic, INC. | $31.67 | 2021 | |
| Bioventus LLC | $28.71 | 2025 | Durolane |
| Davol INC. | $24.96 | 2025 | Avitene Ultrafoam |
| Innovation Technologies INC | $24.34 | 2024 | Irrisept |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $23.87 | 2021 | |
| Pacira Therapeutics, INC. | $23.25 | 2021 | |
| Kci USA, INC. | $18.61 | 2022 | |
| Dynasplint Systems INC. | $14.72 | 2023 | Dynasplint |
| Vericel Corporation | $14.23 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Chatrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.